Selenium, CAD, inflammation and endothelial functio

Phase 1

• Conditions: Coronary artery stenosis; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12606000197538
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-05-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Coronary artery stenosis at least 30% on any of the three major vessels.

Exclusion Criteria

CABG after angiography, myocardial infarct in previous 48Hrsalready taking seleniumhemodynamically significant valvular diseasesurgery or trauma within the past month.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biochemical endothelial function markers Icam and Vcam[At 3 months]

Secondary Outcome Measures

Name	Time	Method
Glutathione peroxidase activity, peroxide and paraoxonase levels.[At 3 months.]